Jeff Paley
Directeur/Membre du Conseil chez IMMUNE PHARMACEUTICALS, INC.
Fortune : 247 545 $ au 30/04/2024
Profil
Jeffrey Paley founded Access Medical Associates LLC in 2003.
Dr. Paley also founded Crimson Biomedical Consulting, where he worked as Chief Executive Officer.
Dr. Paley also currently works at Immune Pharmaceuticals, Inc., as Independent Director from 2016 and Remote Radiology, Inc., as Director.
Dr. Paley also formerly worked at KellBenx, Inc., as Director, Travere Therapeutics, Inc., as Director from 2013 to 2014, Kalytera Therapeutics, Inc., as Director, Avenue Therapeutics, Inc., as Independent Director from 2015 to 2019, Claritas Pharmaceuticals, Inc., as Independent Director, Weill Cornell Internal Medicine Associates, as Director-Clinical Research, Journey Medical Corp., as Independent Director, and Caelum Biosciences, Inc., as Director.
Dr. Paley received his undergraduate degree from Yeshiva University and doctorate degree from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JOURNEY MEDICAL CORP.
0,51% | 28/11/2023 | 70 727 ( 0,51% ) | 247 545 $ | 30/04/2024 |
Postes actifs de Jeff Paley
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/02/2016 |
| Crimson Biomedical Consulting | Directeur Général | - |
| Remote Radiology, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeff Paley
| Sociétés | Poste | Fin |
|---|---|---|
| JOURNEY MEDICAL CORPORATION | Directeur/Membre du Conseil | 07/12/2023 |
| AVENUE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/04/2019 |
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/09/2014 |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Weill Cornell Internal Medicine Associates
 Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Weill Cornell Internal Medicine Associates is a healthcare provider that offers paperless billing to its patients. The private company is located in New York, NY. The company also provides an Executive Health Program to help patients maximize their time and health. | Corporate Officer/Principal | - |
Formation de Jeff Paley
| Yeshiva University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| CLARITAS PHARMACEUTICALS, INC. | Health Technology |
| JOURNEY MEDICAL CORPORATION | Health Technology |
| Entreprise privées | 8 |
|---|---|
| Crimson Biomedical Consulting | |
KellBenx, Inc.
 KellBenx, Inc. Medical SpecialtiesHealth Technology KellBenx, Inc. develops non-invasive prenatal diagnostics for analyzing genetic disorders and to determine a woman's risk of preterm delivery. The company was founded in 2010 and is headquartered in Great River, NY. | Health Technology |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Kalytera Therapeutics, Inc. /Old/
 Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
| Access Medical Associates LLC | |
Weill Cornell Internal Medicine Associates
Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Weill Cornell Internal Medicine Associates is a healthcare provider that offers paperless billing to its patients. The private company is located in New York, NY. The company also provides an Executive Health Program to help patients maximize their time and health. | Health Services |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Health Technology |
| Remote Radiology, Inc. |
